BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• NRGene Delivers First-Ever Food Potato Genomes

  NRGene, the worldwide leader in genomic assembly and analysis, is working with a team of researchers from Wageningen University & Research in the Netherlands and leading commercial partners to create multi-genome mapping of commercial food potatoes.

  December 19, 2017

   · 

  3 min read
• FDA

  Medicure Announces FDA Approval Received for Prexxartan

  The FDA approval of Prexxartan makes it the first and only approved oral liquid dosage form of the ARB valsartan in the United States.

  December 19, 2017

   · 

  4 min read
• Drug Development

  Ovid Therapeutics Announces OV101 Granted Fast Track Designation by U.S. FDA for Treatment of Angelman Syndrome

  Upon successful completion of a Phase 1 pharmacokinetic (PK) and safety study showing that OV101 has a similar PK profile in adolescents as in adults, Ovid recently amended the STARS protocol to include patients aged 13 years and older.

  December 19, 2017

   · 

  5 min read
• Drug Development

  INSYS Therapeutics Initiates Phase II Clinical Trial of Cannabidiol (CBD) Oral Solution for Treatment of Refractory Childhood Absence Epilepsy in Pediatric Patients

  Working with pediatric patients who suffer from this debilitating condition and their clinicians, Insys plans to find out by conducting a study using its pharmaceutical-grade, synthetic CBD.

  December 19, 2017

   · 

  4 min read
• Business

  Apellis Pharma Expands Management Team, Appoints Timothy Sullivan CFO

  Prior to joining as CFO, Sullivan was an observer on Apellis’ board of directors for nearly three years while he was a Partner at AJU IB Investment, a venture capital firm, where he led the firm’s investments in life sciences companies.

  December 19, 2017

   · 

  3 min read
• Pharm Country

  Hemispherx Highlights Year-to-Date Progress, Outlines Key Objectives

  Hemispherx Biopharma announced the posting of a letter to shareholders on its website, www.hemispherx.com, in which CEO Thomas K. Equels reviews corporate activities progress over the past nine months and outlines key objectives going forward.

  December 19, 2017

   · 

  9 min read
• Argenx Announces Closing of U.S. Public Offering for Gross Proceeds of Approximately $26M

  Argenx announced today the closing of its public offering in the United States of 5,106,000 ADSs, at a price of $52.00 per ADS, for gross proceeds of approximately $266M.

  December 19, 2017

   · 

  6 min read
• Lone Star Bio

  Oncolix Announces Approval for Listing on OTC-QB

  Oncolix announced today that the Company has been given approval by the OTC Markets to be listed and traded on the OTC-QB effective at the opening of trading on December 19, 2017.

  December 19, 2017

   · 

  3 min read
• BioMidwest

  DiaMedica Therapeutics Completes Non-Brokered Private Placement

  The proceeds will be used by the Company to support development with DM199 for the treatment of stroke and for other working capital purposes.

  December 19, 2017

   · 

  4 min read
• Pharm Country

  Akers Biosciences Prices $6,000,000 Public Offering

  Akers Biosciences today announces the pricing of an underwritten public offering with expected total gross proceeds of approximately $6,000,000, before deducting underwriting discounts, commissions and other offering expenses payable by the Company.

  December 19, 2017

   · 

  4 min read